EUVIMEDEUVIMED entdecken
Crossref

L26/P-548 Analysis of structural variants identified by Optical Genome Mapping in patients with recurrent implantation failure and recurrent pregnancy loss

F.M. Lozano, B. Lledó, R. Morales, J.A. Ortiz, A. Fuentes, A. Bernabeu

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von F.M. Lozano und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does Optical Genome Mapping enable the detection of cryptic structural variants contributing to infertility in couples affected by recurrent implantation failure and recurrent pregnancy loss? Summary answer High-resolution cytogenetics using Optical Genome Mapping (OGM) detected cryptic structural variations in couples with implantation failures and recurrent miscarriages who underwent assisted reproduction technologies (ART). What is known already Chromosomal structural variants (SVs) are a major genetic cause of infertility, recurrent pregnancy loss (RPL), recurrent implantation failure (RIF), and congenital defects. RPL and RIF are among the reproductive disorders that most strongly limit the success of ART. Detection of these alterations currently relies on conventional cytogenetic methods; however, cryptic chromosomal rearrangements often remain undetected due to limited resolution. OGM is an advanced genomic technology enabling ultra-long single-molecule analysis and high-resolution detection of chromosomal aberrations and SVs (<500 kb). In our clinical trial, we used OGM to identify cryptic SVs in couples with RPL and RIF, clarifying infertility causes. Study design, size, duration This prospective, non-randomized cohort clinical trial included 395 patients: 186 couples and 23 single female patients undergoing assisted reproductive technology between March 2023 and July 2025. Among them, 51% presented recurrent implantation failure and 49% recurrent pregnancy loss. Conventional cytogenetic analysis using G-banded karyotyping showed normal results in all cases. Optical Genome Mapping was applied as a high-resolution diagnostic tool to identify cryptic structural variants potentially underlying infertility in RIF and RPL patients. Participants/materials, setting, methods Ultra High Molecular Weight (UHMW) genomic DNA was isolated from frozen peripheral blood of patients. DNA quantification was performed using the Qubit dsDNA BR Assay and Qubit 4 Fluorometer (Thermo Fisher Scientific). Optical Genome Mapping was conducted on the Saphyr platform (Bionano Genomics), and consensus genome maps were generated by de novo assembly using Bionano Solve. Structural variants (SVs) and breakpoint positions were determined by aligning Optical Genomic Map with the reference genome GRCh38/hg38. Main results and the role of chance The mean female and male ages were 37.3±3.7y and 39.7±5.6y, respectively, with a mean infertility duration of 3.8±1.9y. Overall clinical characteristics were comparable between RPL and RIF groups; as expected, RPL patients had more previous miscarriages (3.6 vs. 0.7, p < 0.001), whereas RIF patients underwent more embryo transfers (2.7 vs 5.3, p < 0.001). OGM generated an average of 823.67Gb per sample. The mean N50 molecule length (≥150 kb) was 318kb. The average mapping rate was 90.75% and the average labelling rate was 15.30 labels per 100kb. The mean effective coverage depth was 242X. OGM identified 32 structural variants among 395 individuals with previous normal karyotype, yielding an overall diagnostic rate of 8.1%. SVs included 19 small inversions (4.8%), 7 large inversions (1.7%), 4 translocations (1.0%), and 2 inter-chromosomal insertions (0.5%). Additionally, 104 small insertions and deletions were identified in genes associated with reproductive function. The frequency of OGM-detected alterations did not differ between RIF and RPL groups (p = 0.418). The comparative analysis showed semen quality differed between men with and without OGM alterations (45.9% vs 67.5%, p = 0.011). Embryo aneuploidy rates were higher in couples with OGM alterations (57.9% vs. 45.3%, p = 0.049), although clinical outcomes were similar, likely due to embryo selection through PGT-A. Limitations, reasons for caution This study has several limitations, including its single-center setting, which may limit generalizability. Functional validation of detected variants was not performed, and clinical interpretation of some SVs remains uncertain. The relatively small number of pathogenic findings reduces statistical power, and PGT-A use may mask potential differences in reproductive outcomes. Wider implications of the findings OGM enabled the detection of cryptic chromosomal structural variants associated with infertility, improving genetic diagnosis. As a next-generation cytogenetic approach, OGM provides high-resolution genome wide analysis and is particularly effective for identifying subtle structural chromosomal alterations that may remain undetected by conventional techniques in couples with RIF and RPL. Trial registration number Yes

Zitieren

APA

Lozano, F., Lledó, B., Morales, R., Ortiz, J., Fuentes, A., & Bernabeu, A. (2026). L26/P-548 Analysis of structural variants identified by Optical Genome Mapping in patients with recurrent implantation failure and recurrent pregnancy loss. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.881

Vancouver

Lozano F, Lledó B, Morales R, Ortiz J, Fuentes A, Bernabeu A. L26/P-548 Analysis of structural variants identified by Optical Genome Mapping in patients with recurrent implantation failure and recurrent pregnancy loss. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.881

BibTeX
@article{Lozano2026,
  author = {Lozano, F.M. and Lledó, B. and Morales, R. and Ortiz, J.A. and Fuentes, A. and Bernabeu, A.},
  title = {L26/P-548 Analysis of structural variants identified by Optical Genome Mapping in patients with recurrent implantation failure and recurrent pregnancy loss},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.881}
}
Kostenlos starten →